Shopping Cart

Genomma Lab Internacional SAB de CV (LABB)-Financial and Strategic SWOT Analysis Review

SKU
GDPH82682FSA
READ MORE
USD 300
Single User License
USD 300
Site License
USD 600
Corporate User License
USD 900

Genomma Lab Internacional SAB de CV (LABB)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clea

READ MORE
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Genomma Lab Internacional SAB de CV (LABB)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genomma Lab Internacional, S.A.B. de C.V. (Genomma Lab) develops, sells and markets branded pharmaceuticals and other healthcare products. The company's product portfolio comprises anti-acne, scar removal ointments, anti-acids, varicose vein treatments, analgesics, anti-fungal, anti-inflammatory, multivitamins, hemorrhoid treatments, colitis treatment, shampoos, flu treatments and others. It also conducts research and development of drugs and personal care products to ensure safety, efficacy and high levels of quality of all its brands. The company operates in the US, Mexico, Peru, Ecuador, Chile, Guatemala, El Salvador, Honduras, Panama, Nicaragua, Argentina, Costa Rica, Bolivia, Colombia and Brazil. Genomma Lab is headquartered at Mexico City, Mexico.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Genomma Lab Internacional SAB de CV-Key Facts 6

Genomma Lab Internacional SAB de CV-Key Employees 7

Genomma Lab Internacional SAB de CV-Major Products and Services 8

Genomma Lab Internacional SAB de CV-History 10

Genomma Lab Internacional SAB de CV-Company Statement 12

Genomma Lab Internacional SAB de CV-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Affiliate 14

Section 2-Company Analysis 15

Genomma Lab Internacional SAB de CV-Business Description 15

Genomma Lab Internacional SAB de CV-Corporate Strategy 16

Genomma Lab Internacional SAB de CV-SWOT Analysis 17

SWOT Analysis-Overview 17

Genomma Lab Internacional SAB de CV-Strengths 17

Strength-Dominant Position 17

Strength-Strong Operational Network 17

Strength-Focused Research and Development Activities 17

Genomma Lab Internacional SAB de CV-Weaknesses 18

Weakness-Declining Revenue: Mexico 18

Weakness-Cost Control 18

Genomma Lab Internacional SAB de CV-Opportunities 19

Opportunity-Strategic Partnership with Walgreens 19

Opportunity-Strategic Divesture 19

Opportunity-Growth Potential in Emerging Markets 19

Genomma Lab Internacional SAB de CV-Threats 20

Threat-Competitive Pressures 20

Threat-Government Regulations 20

Threat-Uncertain R&D Outcomes 20

Genomma Lab Internacional SAB de CV-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 28

Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 29

Genomma Lab Internacional SAB de CV, Recent Deals Summary 30

Section 5-Appendix 31

Methodology 31

Ratio Definitions 31

About GlobalData 35

Contact Us 35

Disclaimer 35


List Of Figure

List of Figures

Genomma Lab Internacional SAB de CV, Performance Chart (2011-2015) 25

Genomma Lab Internacional SAB de CV, Ratio Charts 27

Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 28

Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 29


List Of Table

List of Tables

Genomma Lab Internacional SAB de CV, Key Facts 6

Genomma Lab Internacional SAB de CV, Key Employees 7

Genomma Lab Internacional SAB de CV, Major Products and Services 8

Genomma Lab Internacional SAB de CV, History 10

Genomma Lab Internacional SAB de CV, Subsidiaries 13

Genomma Lab Internacional SAB de CV, Affiliate 14

Genomma Lab Internacional SAB de CV, Key Competitors 21

Genomma Lab Internacional SAB de CV, Ratios based on current share price 22

Genomma Lab Internacional SAB de CV, Annual Ratios 23

Genomma Lab Internacional SAB de CV, Interim Ratios 26

Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 28

Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 29

Genomma Lab Internacional SAB de CV, Recent Deals Summary 30

Currency Codes 31

Capital Market Ratios 31

Equity Ratios 32

Profitability Ratios 32

Cost Ratios 33

Liquidity Ratios 33

Leverage Ratios 34

Efficiency Ratios 34

To know more information on Purchase by Section, please send a mail to

Products

Genomma Lab Internacional SAB de CV, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Brand Description
History Color sit amet, consectetur adipiscing elit. In gravida pellentesque ligula, vel eleifend turpis blandit vel. Nam quis lorem ut mi mattis ullamcorper ac quis dui. Vestibulum et scelerisque ante, eu sodales mi. Nunc tincidunt tempus varius. Integer ante dolor, suscipit non faucibus a, scelerisque vitae sapien.